Tempus Labs, Inc.
Country not established
- Devices
- 1
What Tempus Labs, Inc. makes
Tempus Labs, Inc. develops the xT CDx, a companion diagnostic device designed to analyze genomic data for personalized cancer treatment decisions, enabling targeted therapy selection based on molecular profiling.
The xT CDx is classified as a Class III medical device in the US and is listed under the FDA’s Premarket Approval (PMA) pathway. The company is headquartered in the United States.
Catalogue
xT CDx Ref P210011
Regimes: PMA Registry: PMA
Frequently asked questions
How many devices does Tempus Labs, Inc. have in the registry?
The registry currently lists 1 device for Tempus Labs, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Tempus Labs, Inc.'s devices?
Among its 1 most recently registered device, Tempus Labs, Inc. has devices listed in FDA PMA (1 device).
What risk classes do Tempus Labs, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Tempus Labs, Inc.'s devices are Class III. Each device page shows its own class and authorisation.
What are the newest devices from Tempus Labs, Inc. in the registry?
The most recently registered devices listed for Tempus Labs, Inc. include xT CDx.